@article{cfe94810a5594b24b6f908b59bc3f11d,
title = "Design and subject characteristics in the federally-funded citalopram trial in children with pervasive developmental disorders",
abstract = "The Studies to Advance Autism Research and Treatment Network conducted a randomized trial with citalopram in children with Pervasive developmental disorders (PDDs). We present the rationale, design and sample characteristics of the citalopram trial. Subjects (128 boys, 21 girls) had a mean age of 9.3 (±3.12) years; 132 (88.6%) were diagnosed with autistic disorder (4.7% with Asperger's Disorder; 6.7% with PDD-not otherwise specified). Less than half of the subjects were intellectually disabled; 117 (78.5%) were rated Moderate or Marked on the Clinical Global Impression for Severity. Study measures were similar to previous Research Units on Pediatric Psychopharmacology trials. Subjects in this trial were slightly older and more likely to have complaints of repetitive behavior than participants in RUPP trials.",
keywords = "Autism, Citalopram, Double-blind method, Repetitive behavior, Serotonin reuptake inhibitors",
author = "Lawrence Scahill and McCracken, {James T.} and Karen Bearss and Fay Robinson and Eric Hollander and Bryan King and Joel Bregman and Lin Sikich and Kimberly Dukes and Lisa Sullivan and Evdokia Anagnostou and Craig Donnelly and Kim, {Young Shin} and Louise Ritz and Deborah Hirtz and Ann Wagner",
note = "Funding Information: Acknowledgments This work was funded by National Institutes of Health via the following Studies to Advance Autism Research and Treatment (STAART) center contracts: Boston Univ/Dartmouth-U54-MH066398, Helen Tager-Flusberg, PI; DM-STAT–U01-HD045023, Kimberly Dukes, PI;Mt Sinai–U54–MH066673, Eric Hollander, PI; UCLA–U54-MH068172, Marian Sigman, PI; UNC– U54-MH066418, Joseph Piven, PI; Yale–U54-MH066494, Fred Volkmar, PI; Yale Research Unit on Pediatric Psychopharmacology (RUPP)–U10MH66764, Lawrence Scahill, PI and the CTSA Grant UL1 RR024139 from the National Center for Research Resources (NCRR) to Yale University. The STAART Psychopharmacology Network included the work of Rosemary Affeldt, M.S.W., L.I.C.S.W., Denisse Ambler, M.D., George Anderson, Ph.D., May-Lynn Andresen, R.N., Grace Baranek, Ph.D., Jennifer Bartz, Ph.D., Terrence C. Bethea, M.D., Jennifer Cowen, M.A., Pegeen Cronin, Ph.D., Margaret DeRamus, B.A., Robert Dimino, Ph.D., Tywanda Ellison, Ph.D., Nicole Feirsen, B.A., Lilia Fenelon, B.A., Anita Gordon, M.S.W., Danielle Halpern, Ph.D., Marisa B. Houser, M.S., Cathy Jones, B.A., Lawrence Kaplan, M.D., Paul Kartheiser, M.D., Robyn Keske, M.S.W., M.P.H., Young Shin Kim, M.D., Ph.D., Kathy Koenig, M.S.N., Erin Kustan, B.A., Kathleen Lapp, M.D., Arthur Maerlender, Ph.D., Brenna McDonald, Psy.D., M.B.A., Debra McQuade, Ph.D., M.D., Shana Nichols, Ph.D., Roumen Nikolov, M.D., Maryellen Pachler, M.S.N., Emily Quinn, M.A., Idania Ra-mirez, M.P.H., Jennifer Richards, M.D., Peter Robichaux, B.A., Jade Rusoff, B.A., Bhavik Shah, M.D., Latha Soorya, Ph.D., Linda Spritzer, B.A., Erika Swanson, B.A., Tara Tripp, M.A., John Vidaver, M.A., Shulamit Waldoks, B.A., A. Ting Wang, Ph.D., Stacey Wasserman, M.D., Emily Williams, M.Ed.",
year = "2012",
month = mar,
doi = "10.1007/s10803-011-1251-8",
language = "English (US)",
volume = "42",
pages = "432--440",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "3",
}